Our pharmaceutical Quats are manufactured in accordance with cGMP Guide ICH Q7 for Active Pharmaceutical Ingredients, the highest available standard. We analyse according to relevant multicompendial pharmacopoeias (e.g. Ph.Eur., USP/NF, JP, BP and ChP). Our pharmaceutical Quats are used in many different products such as ophthalmic, nasal sprays, topical products, oral/dental products and medical devices. Our Quats include Benzalkonium Chloride (BKC), Cetrimide and CTAB.
Our recombinant Insulin Human AF is a key component in serum-free growth media for mammalian cells, used for the manufacturing of monoclonal antibodies, virus vaccines, gene therapy products and other biological drugs approved by regulatory bodies worldwide.
Both Novo Nordisk and Novo Nordisk Pharmatech are regularly audited by major and minor pharmaceutical companies and inspected by the Danish Medicine Agency.
Our comprehensive documentation and services include:
* Applies only for our Quats products.
Novo Nordisk Pharmatech’s quality management system is in compliance with DS/EN ISO 9001 in all of our activities and includes production, QA/QC, sales and marketing, R&D, shipping information and customer services. The high quality of our products is ensured by our efficient quality assurance systems and quality control carried out by highly experienced professionals.
Environmental considerations are an integral part of our everyday work. Our main concerns include reducing atmospheric emissions of organic solvents from the production process, and carbon dioxide and nitrogen oxide from the production of energy. We have implemented an Environmental Policy and are DS/EN ISO 14001 as well as IS0 45001 certified.
Click below to read our:
Insulin Human products are registered by Novo Nordisk. Our FeF® Cetrimide, FeF® CTAB and FeF® Benzalkonium Chloride products are all registered with ECHA. See our registration numbers here.
We are involved in the relevant SIEF groups, either as a Lead Registrant or as an active participant.